Özge Üçüncü

Özge Üçüncü

Auto-generated profile, based on publicly available information

Özge Üçüncü

Department of Endocrinology and Metabolism, Karadeniz Technical University Faculty of Medicine, Trabzon, Türkiye

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2026 in Journal of Clinical and Analytical Medicine
Verified
Journal Article
Closed access
ÖÜÖzge Üçüncü
Özge Üçüncü
HEHalil Önder Ersöz
Halil Önder Ersöz
MSMehmet Sönmez
Mehmet Sönmez
AÖAsım Örem
Asım Örem
NUNergis Usta
Nergis Usta
CECihangir Erem
Cihangir Erem
Aim Polycystic ovary syndrome (PCOS) is associated with increased cardiovascular disease (CVD) risk, particularly with insulin resistance (IR). Endothelial progenitor cells (EPCs) contribute to vascular repair. This study evaluated circulating EPC number in women with anovulatory PCOS with and without IR, and its relationship with cardiovascular risk markers. Methods In this cross-sectional study, 40 newly diagnosed, treatment-naïve women with anovulatory PCOS (2003 Rotterdam criteria) were divided into two groups of 20 according to the presence or absence of IR (HOMA-IR ≥2.7), and compared with 20 age- and sex-matched healthy controls. Circulating EPCs (CD34+/CD133+/VEGFR-2+ cells) were quantified by flow cytometry. Metabolic, hormonal and inflammatory parameters, together with serum VEGF, ICAM-1, VCAM-1, E-selectin and MMP-9, were measured by ELISA. Results Glucose, triglyceride, hs-CRP, fibrinogen, ferritin, E-selectin and MMP-9 were significantly higher, and HDL-cholesterol significantly lower, in the IR-positive group compared with controls (P < .05). ICAM-1 and VEGF did not differ significantly among groups. In the IR-negative group, VCAM-1 was the only inflammatory or endothelial marker significantly higher than in controls (P = .010). Circulating EPC numbers did not differ significantly between either PCOS group and controls, and EPC counts correlated weakly with FSH (Spearman rho=0.258, P = .046; exploratory). Conclusion In young, newly diagnosed women with PCOS, inflammatory and endothelial-activation markers were increased predominantly in the IR-positive group, which also had a higher BMI, so the effects of IR and adiposity cannot be separated. Circulating EPC numbers did not differ significantly between groups; larger studies with functional EPC assays are needed.

31 March 2023 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
YGYasemin Emür Günay
Yasemin Emür Günay
SDSerdar Durak
Serdar Durak
OÜOzge Üçüncü
Ozge Üçüncü
ACArif Mansur Cosar
Arif Mansur Cosar
Purpose: The prevalence of precancerous or cancerous lesions in the upper gastrointestinal tract in acromegalic patients is not well known. The aim of this study is to evaluate the endoscopic findings of the upper gastrointestinal system (GIS) of patients with acromegaly and to assess whether the pathological findings are related to the disease and the use of somatostatin analogs. Materials and Methods: Between January 2010 and October 2021, patients diagnosed with acromegaly were identified by retrospective medical record scanning. This study included 49 patients with acromegaly who underwent upper GIS endoscopy. The acromegaly patients were divided into two groups: those who were taking somatostatin analogs at the time of endoscopy and those who were not. It was investigated whether there was a difference between these two groups in terms of lesion development. The patients with acromegaly and the control group were compared in terms of endoscopic findings and biopsy results. Results: Of these patients, 53% (n=26) were male and 46.9% (n=23) were female. The incidence of Helicobacter pylori (HP) was significantly higher in the acromegaly patients than in the control subjects. In the acromegaly group, 62.5% (n=15) of the 24 patients with antral and pangastritis were taking somatostatin analogs. There was no significant difference between the use of somatostatin analogs and the development of gastritis. The development of esophagitis was statistically higher in patients with acromegaly taking somatostatin analogs. Conclusion: The incidence of HP was higher in patients with acromegaly than in the normal population. No clear results were found regarding the development of gastritis. The incidence of esophagitis was high in acromegalic patients taking somatostatin analogs. Large-scale studies are needed to uncover the relationship between the etiology of the disease and the drugs taken.

1 September 2026 in Endocrinology Research and Practice
Verified
Journal Article
Open access
PDF file
SUSena Ustaömer
Sena Ustaömer
MDMefküre Durmuş
Mefküre Durmuş
ÖÜÖzge Üçüncü
Özge Üçüncü
MKMustafa KOCAK
Mustafa KOCAK
Objective: Hypothyroidism requires lifelong levothyroxine (LT4) therapy, yet achieving target thyroid-stimulating hormone (TSH) levels is often hindered by complex drug–food interactions and poor adherence. This study evaluated the impact of clinical pharmacist-led education on LT4 adherence and treatment effectiveness. Methods: This uncontrolled pre–post interventional study was conducted between November 2024 and April 2025 in an endocrinology outpatient clinic. Patients diagnosed with hypothyroidism initiating LT4 therapy were included. Baseline sociodemographic data and medication habits were recorded, and adherence was assessed using the Turkish-validated Medication Adherence Report Scale-5 (MARS-5). Participants received a 10-min structured verbal education session and an informative brochure. After 3 months, a follow-up was conducted via telephone to re-administer MARS-5 and retrieve serum TSH and free thyroxine (fT4) values from hospital records. Results: Among 152 participants (median age 51; 86.2% female), the median MARS-5 score significantly increased from 24.0 (interquartile range (IQR) 22.0-25.0) to 25.0 (IQR 24.0-25.0; P < .001). Median TSH levels significantly decreased from 2.04 (0.80-3.95) to 1.17 (0.39-3.16) mIU/L (P =.002), while fT4 levels remained stable. Notably, the proportion of patients taking LT4 at least 30 min before breakfast improved from 45.7% to 96.7% (P < .001). Conclusion: A brief, structured clinical pharmacist-led intervention significantly improved LT4 adherence and biochemical treatment outcomes. These findings underscore the clinical value of integrating pharmacist-led education and follow-up services into routine outpatient care to optimize long-term management of hypothyroidism. Cite this article as: Ustaömer S, Durmuş M, Üçüncü Ö, Koçak M. Improving levothyroxine adherence and thyroid-stimulating hormone control via structured clinical pharmacist-led education in patients with hypothyroidism. Endocrinol Res Pract. Published online September 1, 2026. doi: 10.5152/erp.2026.26986.

9 March 2026 in Endocrinology Research and Practice
Verified
Journal Article
Closed access
BVBarış Yasin Varlık
Barış Yasin Varlık
ÖMÖzlem Kanburoğlu Meletli
Özlem Kanburoğlu Meletli
ÖÜÖzge Üçüncü
Özge Üçüncü
ŞEŞafak Ersöz
Şafak Ersöz
Adrenal ganglioneuromas are rare, well-differentiated tumors of sympathetic origin derived from neural crest cells. This case presents a non-functional but radiologically suspicious right adrenal mass, which was removed laparoscopically and histopathologically diagnosed as a ganglioneuroma. A 25-year-old male presented with dysuria. Abdominal magnetic resonance imaging revealed a 55 × 34 mm right adrenal mass. Ambulatory blood pressure monitoring showed no hypertension. Hormonal evaluation excluded pheochromocytoma, hyperaldosteronism, and hypercortisolism. Dehydroepiandrosterone sulfate was within the normal range. On the adrenal wash-out protocol computed tomography, the relative wash-out was −16.3% and absolute wash-out −87.5%, suggesting a non-adenomatous lesion. Laparoscopic right adrenalectomy was performed under the pre-diagnosis of a non-functional, non-adenomatous adrenal mass. Histopathological examination revealed a 6.5 × 4.7 cm ganglioneuroma. Density and wash-out parameters are insufficient to rule out malignancy in non-functional adrenal lesions. Surgical resection is appropriate for lesions ≥4 cm, with attenuation >20 Hounsfield Unit and atypical wash-out features. Following laparoscopic adrenalectomy for non-adrenocortical benign neoplasms, the prognosis is excellent, and recurrence is exceedingly rare. Cite this article as: Varlık BY, Meletli ÖK, Üçüncü Ö, Ersöz Ş. Malignant-appearing adrenal ganglioneuroma: case report of a 25-year-old male with a right adrenal mass. Endocrinol Res Pract. Published online March 2, 2026. doi: 10.5152/erp.2026.26840